优化癌症分类:用于特征选择和预测洞察力的混合RDO-XGBoost方法
Abrar Yaqoob1, Navneet Kumar Verma2, Rabia Musheer Aziz3
1VIT Bhopal University's School of Advanced Science and Language, Located at Kothrikalan, Sehore, Bhopal, 466114, India. abraryaqoob77@gmail.com.
Cancer immunology, immunotherapy : CII
|October 9, 2024
概括
这项研究引入了一种新方法,将随机漂移优化 (RDO) 与 XGBoost 结合起来,用于癌症生物标志物发现. 该方法提高了癌症分类的准确性,并确定了用于改进分析的关键基因.
科学领域:
- 计算生物学 计算生物学
- 生物信息学是一种生物信息学.
- 基因组学就是基因组学.
背景情况:
- 由于复杂性和异质性,高维的癌症数据对生物标志物识别提出了挑战.
- 传统的特征选择方法在复杂的癌症数据集中往往缺乏效率和预测准确性.
研究的目的:
- 开发一种新的特征选择框架,将随机漂移优化 (RDO) 与 XGBoost 集成,以提高癌症分类.
- 改进相关生物标志物的识别,并深入了解癌症进展机制.
主要方法:
- 整合随机漂移优化 (RDO) 与XGBoost算法进行特征选择.
- 关于各种现实癌症数据集的拟议框架的应用和验证 (中枢神经系统,白血病,乳腺癌,卵巢癌).
- 与支持向量机,K-近邻和天真贝叶斯分类器进行比较分析.
主要成果:
- RDO-XGBoost框架显著提高了多种癌症类型的分类准确性和效率.
- 成功地确定了一组较小的独特和相关基因子集,有助于理解癌症生物学.
- 实现了高准确率:97.24% (中枢神经系统),99.14% (白血病),95.21% (卵巢) 和87.62% (乳腺癌).
结论:
- 与癌症数据分析的传统分类器相比,RDO-XGBoost框架显示出更高的性能.
- 该方法为强大的特征选择,增强的预测性能和癌症研究中的生物见解提供了有前途的解决方案.
相关概念视频
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Receiver Operating Characteristic Plot
94
A ROC (Receiver Operating Characteristic) plot is a graphical tool used to assess the performance of a binary classification model by illustrating the trade-off between sensitivity (true positive rate) and specificity (false positive rate). By plotting sensitivity against 1 - specificity across various threshold settings, the ROC curve shows how well the model distinguishes between classes, with a curve closer to the top-left corner indicating a more accurate model. The area under the ROC curve...
94
Sensitivity, Specificity, and Predicted Value
209
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
Sensitivity is the...
209
Aggregates Classification
305
Aggregate classification is generally based on its size, petrographic characteristics, weight, and source. Size classification ranges from coarse to fine aggregates, defined by the size of the particles. Coarse aggregates are particles that do not pass through ASTM sieve No. 4, and aggregates that pass through the sieve are fine aggregates.
Petrographic classification groups aggregates based on common mineralogical characteristics. Some of the common mineral groups found in aggregates are...
Petrographic classification groups aggregates based on common mineralogical characteristics. Some of the common mineral groups found in aggregates are...
305
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


